Dr. Anabtawi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3901 Rainbow Blvd
Stop 2024
Kansas City, KS 66160Phone+1 913-588-6022Fax+1 913-535-2101
Education & Training
- University of Kansas School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2013
- Rochester Regional Health/Unity Hospital (Rochester)Residency, Internal Medicine, 2008 - 2011
- University of Jordan Faculty of MedicineClass of 2006
Certifications & Licensure
- KS State Medical License 2011 - 2024
- MO State Medical License 2021 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 12 citationsCGM patterns in adults with cystic fibrosis-related diabetes before and after elexacaftor-tezacaftor-ivacaftor therapy.Hanna Crow, Charles Bengtson, Xiaosong Shi, Leland Graves 3rd, Abeer Anabtawi
Journal of Clinical & Translational Endocrinology. 2022-12-01 - 1 citationsRomosozumab used to treat a patient with cystic fibrosis-related osteoporosis.Hanna M Crow, Leland Graves, Abeer Anabtawi
The American Journal of the Medical Sciences. 2022-10-01 - 2 citationsTrabecular bone score in people with cystic fibrosis.A Anabtawi, M Holyoak, J He, E Cristiano, D Polineni
Osteoporosis International. 2022-05-01
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: